| HGNC Family | Non-coding RNAs |
| Name | small nucleolar RNA, C/D box 66 |
| Description | Predicted to be involved in RNA processing. Predicted to be located in nucleolus. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nNote that none of the provided abstracts discuss SNORD66. Instead, they all focus on SNF5 (also known as SMARCB1 or INI1), a core subunit of the SWI/SNF chromatin remodeling complex that functions as a potent tumor suppressor. SNF5 plays a key role in orchestrating epigenetic programs by modulating chromatin structure and gene transcription. It antagonizes oncogenic factors such as EZH2, regulates stem cell–associated transcriptional programs, and governs cell cycle progression; its loss leads to aberrant H3K27 trimethylation, misregulation of differentiation-associated genes, and activation of oncogenic pathways that contribute to aggressive tumor formation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its role in transcriptional regulation, SNF5 is essential for maintaining proper nucleosome positioning and chromatin architecture. Perturbations in its activity disrupt the balance of key signaling pathways—including Hedgehog, p53-dependent DNA damage responses, and pathways governing cell metabolism and differentiation—which in turn can lead to genomic instability and tumorigenesis. Conditional inactivation studies in primary cells and various mouse models demonstrate that loss of SNF5 function not only impairs cell survival and differentiation (with effects seen, for example, in the liver, central nervous system, and renal medulla) but also sensitizes cells to additional genetic insults, thereby accelerating malignant transformation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "10"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMoreover, genetically engineered mouse models reveal that SNF5 loss cooperates with other genetic alterations (such as p53 inactivation or reliance on residual components like BRG1) to promote a spectrum of tumors—including rhabdoid tumors, T-cell lymphomas, and other aggressive malignancies. These studies highlight that restoring proper chromatin remodeling function or targeting downstream oncogenic signaling (e.g., through inhibitors of pathways activated by SNF5 loss) may provide promising therapeutic avenues in SNF5‐deficient cancers. Overall, the wide-ranging influence of SNF5 on chromatin dynamics, transcriptional fidelity, and cell cycle control underscores its essential role in both normal development and tumor suppression."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "11", "end_ref": "19"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Boris G Wilson, Xi Wang, Xiaohua Shen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccr.2010.09.006"}], "href": "https://doi.org/10.1016/j.ccr.2010.09.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20951942"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20951942"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Charles W M Roberts, Monique M Leroux, Mark D Fleming, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s1535-6108(02)00185-x"}], "href": "https://doi.org/10.1016/s1535-6108(02"}, {"type": "t", "text": "00185-x) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12450796"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12450796"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Zainab Jagani, E Lorena Mora-Blanco, Courtney G Sansam, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm.2251"}], "href": "https://doi.org/10.1038/nm.2251"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21076395"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21076395"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Michael S Isakoff, Courtney G Sansam, Pablo Tamayo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0509014102"}], "href": "https://doi.org/10.1073/pnas.0509014102"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16301525"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16301525"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Michael Y Tolstorukov, Courtney G Sansam, Ping Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Swi/Snf chromatin remodeling/tumor suppressor complex establishes nucleosome occupancy at target promoters."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1302209110"}], "href": "https://doi.org/10.1073/pnas.1302209110"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23723349"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23723349"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Xi Wang, Courtney G Sansam, Christopher S Thom, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-09-0733"}], "href": "https://doi.org/10.1158/0008-5472.CAN-09-0733"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19789351"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19789351"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Agnes Klochendler-Yeivin, Eli Picarsky, Moshe Yaniv "}, {"type": "b", "children": [{"type": "t", "text": "Increased DNA damage sensitivity and apoptosis in cells lacking the Snf5/Ini1 subunit of the SWI/SNF chromatin remodeling complex."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.26.7.2661-2674.2006"}], "href": "https://doi.org/10.1128/MCB.26.7.2661-2674.2006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16537910"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16537910"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Elizabeth S McKenna, Courtney G Sansam, Yoon-Jae Cho, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.00658-08"}], "href": "https://doi.org/10.1128/MCB.00658-08"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18710953"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18710953"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Zhi-Yan Han, Wilfrid Richer, Paul Fréneaux, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The occurrence of intracranial rhabdoid tumours in mice depends on temporal control of Smarcb1 inactivation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms10421"}], "href": "https://doi.org/10.1038/ncomms10421"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26818002"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26818002"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Lionel Gresh, Brigitte Bourachot, Andreas Reimann, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The SWI/SNF chromatin-remodeling complex subunit SNF5 is essential for hepatocyte differentiation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO J (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.emboj.7600802"}], "href": "https://doi.org/10.1038/sj.emboj.7600802"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16138077"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16138077"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Jeremie Vitte, Fuying Gao, Giovanni Coppola, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-017-00346-5"}], "href": "https://doi.org/10.1038/s41467-017-00346-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28824165"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28824165"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Alessandro Carugo, Rosalba Minelli, Luigi Sapio, et al. "}, {"type": "b", "children": [{"type": "t", "text": "p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccell.2019.01.006"}], "href": "https://doi.org/10.1016/j.ccell.2019.01.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30753823"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30753823"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Cynthia J Guidi, Rajini Mudhasani, Kathleen Hoover, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Functional interaction of the retinoblastoma and Ini1/Snf5 tumor suppressors in cell growth and pituitary tumorigenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-06-1451"}], "href": "https://doi.org/10.1158/0008-5472.CAN-06-1451"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16912184"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16912184"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "J Darr, A Klochendler, S Isaac, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2013.261"}], "href": "https://doi.org/10.1038/onc.2013.261"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23851500"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23851500"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Y Xu, W Yan, X Chen "}, {"type": "b", "children": [{"type": "t", "text": "SNF5, a core component of the SWI/SNF complex, is necessary for p53 expression and cell survival, in part through eIF4E."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2010.159"}], "href": "https://doi.org/10.1038/onc.2010.159"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20473326"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20473326"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Jessica DelBove, Yasumichi Kuwahara, E Lorena Mora-Blanco, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inactivation of SNF5 cooperates with p53 loss to accelerate tumor formation in Snf5(+/-);p53(+/-) mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Carcinog (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mc.20568"}], "href": "https://doi.org/10.1002/mc.20568"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19676100"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19676100"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Alina Filatova, Linda K Rey, Marion B Lechler, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in SMARCB1 and in other Coffin-Siris syndrome genes lead to various brain midline defects."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-019-10849-y"}], "href": "https://doi.org/10.1038/s41467-019-10849-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31273213"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31273213"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Megumi Sakakura, Sho Ohta, Masaki Yagi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Smarcb1 maintains the cellular identity and the chromatin landscapes of mouse embryonic stem cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2019.09.054"}], "href": "https://doi.org/10.1016/j.bbrc.2019.09.054"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31543342"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31543342"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Anja Fischer, Thomas K Albert, Natalia Moreno, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-024-52826-0"}], "href": "https://doi.org/10.1038/s41467-024-52826-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "39362842"}], "href": "https://pubmed.ncbi.nlm.nih.gov/39362842"}]}]}]}
|
| Synonyms | HBII-142 |
| NCBI Gene ID | 692107 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
SNORD66 has 430 functional associations with biological entities spanning 3 categories (molecular profile, cell line, cell type or tissue, gene, protein or microRNA) extracted from 12 datasets.
Click the + buttons to view associations for SNORD66 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of SNORD66 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SNORD66 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of SNORD66 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of SNORD66 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SNORD66 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SNORD66 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of SNORD66 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of SNORD66 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of SNORD66 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of SNORD66 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of SNORD66 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SNORD66 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |